Epizyme Falls as Investors Take in Disappointing Phase II Data

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Epizyme Falls as Investors Take in Disappointing Phase II Data" ALT"Epizyme Falls as Investors Take in Disappointing Phase II Data"June 15, 2017By Alex Keown, BioSpace.com Breaking News Staff...…

Continue ReadingEpizyme Falls as Investors Take in Disappointing Phase II Data

New Biotech Incubator Just Opened Up in the Big Apple&mdash;With Room for 25 Startups

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-alexandria-launchlabs.jpg" NAME"New Biotech Incubator Just Opened Up in the Big AppleWith Room for 25 Startups" ALT"New Biotech Incubator Just Opened Up in the Big AppleWith Room for 25 Startups"June…

Continue ReadingNew Biotech Incubator Just Opened Up in the Big Apple&mdash;With Room for 25 Startups

UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D" ALT"UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster…

Continue ReadingUK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D

Google's Verily and Novartis AG Jump Into Medicxi's $300 Million Life Science Investment Fund

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Google's Verily and Novartis Jump Into Medicxi's $300 Million Life Science Investment Fund" ALT"Google's Verily and Novartis Jump Into Medicxi's $300 Million Life Science Investment Fund"June 15, 2017By…

Continue ReadingGoogle's Verily and Novartis AG Jump Into Medicxi's $300 Million Life Science Investment Fund

What Biogen CFO's Departure Means for Company's M&A Strategy

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x470-biogen.jpg" NAME"What Biogen CFO's Departure Means for Company's M&A Strategy" ALT"What Biogen CFO's Departure Means for Company's M&A Strategy"June 15, 2017By Mark Terry, BioSpace.com Breaking News StaffEverybody... Source: BioSpace

Continue ReadingWhat Biogen CFO's Departure Means for Company's M&A Strategy